Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Excel Venture Management Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
5,456,189Website Global Rank
1,702Website Monthly Traffic
Twitter Followers
Description
Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, and medical devices, plus life science platforms that address adjacent markets including energy, chemicals, defense and agriculture. The majority of the team’s prior investments, which include some of the world’s premier healthcare and life science companies, are thriving and over half have achieved successful exits generating billions in value. Excel Venture Management is a spin-off of CB Health Ventures.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2011 | nanoMR | Series B | 13M |
| 1/2008 | Forhealth Technologies | Venture Round | - |
| 9/2018 | InfoBionic | Venture Round | 0 |
| 1/2008 | CareMedic Systems | Venture Round | - |
| 4/2010 | Intrapace | Venture Round | 49M |
| 4/2009 | BioTrove | Series C | - |
| 1/2013 | Aileron Therapeutics | Series D | 12M |
| 12/2014 | Foodsmart | Series A | 5M |
| 1/2010 | Virgin Pulse | Venture Round | - |
| 7/2014 | Molecular Templates | Venture Round | 7M |
| 5/2015 | ClearDATA | Series C | 25M |
| 11/2013 | Aileron Therapeutics | Series E | 30M |
| 1/2020 | Gemphire Therapeutics | Private Equity Round | - |
| 1/2015 | BIOCIUS Life Sciences | Private Equity Round | - |
| 10/2012 | Cleveland HeartLab | Series B | 14.7M |
| 7/2011 | Springleaf Therapeutics | Series B | 19M |
| 8/2013 | ClearDATA | Series B | 7M |
| 1/2009 | Carefx | Venture Round | - |
| 1/2021 | Orionis Biosciences | Private Equity Round | - |
| 8/2010 | ShapeUp | Series A | 8M |
| 1/2019 | Neosensory | Series A | 10M |
| 3/2010 | Saladax Biomedical | Series C | 8.4M |
| 6/2010 | Catch.com, Inc. | Seed Round | 2.3M |
| 1/2008 | Skylight Healthcare Systems | Series C | 3M |
| 2/2011 | Catch.com, Inc. | Series A | 7M |
| 1/2015 | Qstream | Series A | 4M |
| 9/2009 | MedVentive | Series C | 7.2M |
| 1/2009 | Xcellerex | Venture Round | - |
| 6/2010 | Viridos | Venture Round | 35M |
| 8/2011 | Lantos Technologies | Venture Round | 4.1M |
| 6/2009 | Exact Sciences | Post-IPO Equity | 8.2M |
| 3/2017 | ClearDATA | Series D | 12M |
| 1/2008 | IPC-The Hospitalist Company | Venture Round | - |
| 12/2015 | Welldoc | Series B | 0 |
| 10/2013 | Molecular Templates | Series C | 8.5M |
| 9/2010 | Lantos Technologies | Venture Round | 1.6M |
| 10/2013 | Pathogenetix | Series C | 10M |
| 8/2011 | Pathogenetix | Series B | 4M |
| 11/2013 | ShapeUp | Series B | 5M |
| 8/2011 | Cleveland HeartLab | Series B | 0 |
| 6/2009 | Aileron Therapeutics | Series D | 40M |
| 2/2015 | Aventura Software | Series C | 14M |
| 10/2011 | MedVentive | Series D | 0 |
| 9/2011 | Aventura Software | Series A | 13M |
| 1/2008 | Emageon | Post-IPO Equity | - |
| 7/2016 | N-of-One | Series B | 7M |
| 9/2013 | Aventura Software | Series B | 4.3M |
| 11/2018 | ClearDATA | Series E | 0 |
| 5/2020 | Ayogo Health | Series B | 0 |
| 7/2016 | InfoBionic | Series B | 0 |
| 3/2018 | Openwater | Seed Round | - |
| 10/2014 | Aileron Therapeutics | Series E | 33M |
| 9/2012 | IlluminOss Medical | Series C | 0 |
| 12/2016 | Qstream | Series B | 15M |
| 12/2018 | Openwater | Series A | 22M |
| 11/2016 | Foodsmart | Series B | 0 |
| 2/2008 | Zonare Medical Systems | Equity | 30M |
| 1/2008 | Passport Health Communications | Venture Round | - |
| 11/2012 | Activate Networks | Series B | 0 |
| 3/2010 | TransMedics | Series E | 0 |
| 6/2010 | Tetraphase Pharmaceuticals | Series C | 0 |
| 4/2015 | Ayogo Health | Series A | 2.5M |
| 1/2008 | Virscio | Venture Round | - |
| 1/2017 | Oculus Health | Series A | - |
| 11/2011 | Pathogenetix | Series B | 7.5M |
| 1/2021 | Orionis Biosciences | Private Equity Round | - |
| 5/2020 | Ayogo Health | Series B | 0 |
| 1/2020 | Gemphire Therapeutics | Private Equity Round | - |
| 1/2019 | Neosensory | Series A | 0 |
| 12/2018 | Openwater | Series A | 0 |
| 11/2018 | ClearDATA | Series E | 0 |
| 9/2018 | InfoBionic | Venture Round | 0 |
| 3/2018 | Openwater | Seed Round | - |
| 3/2017 | ClearDATA | Series D | 0 |
| 1/2017 | Oculus Health | Series A | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
